Clinical scoring systems | Versions | Age groups (years) | Population (development and validation) | Used in MLD before |
---|---|---|---|---|
GMFC-MLD [27] | 1 version | 1.5–18, [>18] | MLD patients | |
ELFC-MLD [28] | 1 version | 1.5–18, [>18] | MLD patients | |
EDACS [29] | 1 version | 2–21, [>21] | CP patients | |
MACS [30] | MACS Mini-MACS | 4–18, [>18] 1–4 | CP patients | Yes, unpublished |
Measurement tools | Versions | Age groups (years) | Population (development and validation) | Used in MLD before |
---|---|---|---|---|
IQ | Many different tools |  > 2.5 | Non-specific populations | Yes, frequently* |
MMSE [43] | 1 version |  > 18 | Non-specific adult populations | Yes, unpublished |
GMFM-88 [44] | GMFM-88 & GMFM-66 | 0.4–16, [> 16] | Non-specific pediatric populations | |
SARA [48] | 1 version | [≥ 3], > 8 | Different SCA- and non-SCA populations with ataxia | Yes, unpublished |
PROMs | Versions | Age groups (years) | Population (development and validation) | Used in MLD before |
---|---|---|---|---|
Modes of administration (self-assessment, interviewer-administered, and proxy), age groups | 4–7, 8–15, > 15 | Non-specific populations | No | |
HUI3 [52] | Modes of administration (self-assessment, interviewer- administered, and proxy) | > 1 | Non-specific populations | No |
Age groups | 2–4, 5–7, 8–12, 13–18 | Non-specific pediatric populations | Yes [55]** |